ArticleCureus2025
From Liver to Lung: A Pathological Journey of Bilothorax.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bilothorax is a rare and pathological condition characterized by the accumulation of bile in the pleural cavity. This phenomenon most commonly occurs on the right side due to anatomical proximity to the liver and biliary system. Bilateral or left-sided bilothorax remains exceedingly rare. Diagnosis relies on pleural fluid analysis, particularly a pleural-to-serum bilirubin ratio >1, and imaging. We report the case of a male patient in his mid-60s with hepatitis C-related cirrhosis (Child-Pugh B7), hepatocellular carcinoma with pulmonary metastases, and multiple comorbidities, including diabetes mellitus and portal hypertension. The patient was undergoing systemic therapy with atezolizumab and bevacizumab, presented with chronic infected wounds and systemic symptoms and later developed gallbladder perforation with biliary peritonitis. Despite multidisciplinary management including percutaneous drainage, intravenous antibiotics, and intensive care support, his condition deteriorated. Subsequently, he developed a right-sided bilothorax, confirmed via thoracentesis, with a pleural-to-serum bilirubin ratio of 3.4 (normal < 0.6). Cultures isolated Enterobacter, and the patient was treated with targeted antibiotics and chest tube drainage. However, he experienced progressive hepatic decompensation, recurrent sepsis, and respiratory failure, ultimately leading to a transition to hospice care. This case is noteworthy due to the extreme rarity of bilothorax, the diagnostic complexity in distinguishing it from other pleural effusions, and the management challenges it poses in patients with advanced cirrhosis and malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.